Latest Breaking News On - Department of bone marrow transplantation - Page 1 : comparemela.com

Memphis People in Business: May 16, 2024

A look at promotions, hirings, movers and newsmakers in the Memphis area business scene

United statesUniversity of memphisUniversity of tennesseeMichel lebelPadmaraj duvvuriTim romanowAllen hoshallChris brubakerSemmes murpheyStacy mccallKenan arnautovicKeith turbettKimberly guthrieSylvia richeyBob mceniryIris restaurant group

Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation

Immix Biopharma Announces Positive NXC-201 Relapsed/Refractory AL Amyloidosis Clinical Data in ASGCT 2024 Late Breaking Oral Presentation
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesMike moyerGabriel morrisIlya rachmanPolina stepenskyView researchCompany contactCompany annual report on formHadassah medical organizationDepartment of bone marrow transplantationAmerican society of geneGlobenewswire incBaltimore convention centerExchange commissionImmix biopharma incYork heart association

CARGO Therapeutics Announces Scientific Advisory Board

CARGO Therapeutics Announces Scientific Advisory Board
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesDana farber cancer instituteStephen gottschalkRobbie majznerMaura gavaghanMarcela mausPaula okeefeAndras attila heczeyCancer centerTherapeutics incCell therapy division of oncologyProfessor at harvard medical schoolDepartment of bone marrow transplantationYoung adult cancer cell therapy programUniversity of sydney

Immix Biopharma Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting

100% overall response rate and 67% complete response rate observed in heavily pre-treated patients with daratumumab relapsed/refractory AL Amyloidosis as of the September 20, 2023 data cutoff100% .

Grand viewUnited statesMike moyerGabriel morrisPolina stepenskyIiia iiibIlya rachmanLos angelesInternational myeloma society annual meetingHadassah medical organizationDepartment of bone marrow transplantationInternational myeloma working groupInternational myeloma society annualGlobenewswire incCompany contactImmix biopharma inc

Exclusive - A New Strategy for Immunotherapy of Cancer

Exclusive - A New Strategy for Immunotherapy of Cancer
isracast.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from isracast.com Daily Mail and Mail on Sunday newspapers.

Hebrew universityIsrael generalSlavins allogeneicLewis thomasRichmond prehnMichael har noyMacfarlane burnetEpstein barrMedicinab airesHebrew university medical centerDepartment of bone marrow transplantationQuality medical publishing incImmunovative therapies ltdSir macfarlane burnetBone marrow transplantationHadassah hebrew university medical center